<VariationArchive VariationID="2005909" VariationName="NM_001282225.2(ADA2):c.239del (p.Phe80fs)" VariationType="Deletion" Accession="VCV002005909" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-20" DateCreated="2023-02-08" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2072855" VariationID="2005909">
      <GeneList>
        <Gene Symbol="ADA2" FullName="adenosine deaminase 2" GeneID="51816" HGNC_ID="HGNC:1839" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>22q11.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="17178790" stop="17221848" display_start="17178790" display_stop="17221848" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="17660191" stop="17690778" display_start="17660191" display_stop="17690778" Strand="-" />
          </Location>
          <OMIM>607575</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001282225.2(ADA2):c.239del (p.Phe80fs)</Name>
      <CanonicalSPDI>NC_000022.11:17209438:AA:A</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>22q11.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="17209439" stop="17209439" display_start="17209439" display_stop="17209439" variantLength="1" positionVCF="17209438" referenceAlleleVCF="GA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="17690329" stop="17690329" display_start="17690329" display_stop="17690329" variantLength="1" positionVCF="17690328" referenceAlleleVCF="GA" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>F38fs</ProteinChange>
      <ProteinChange>F80fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000022.10" sequenceAccession="NC_000022" sequenceVersion="10" change="g.17690330del" Assembly="GRCh37">
            <Expression>NC_000022.10:g.17690330del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000022.11" sequenceAccession="NC_000022" sequenceVersion="11" change="g.17209440del" Assembly="GRCh38">
            <Expression>NC_000022.11:g.17209440del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033943.1" sequenceAccession="NG_033943" sequenceVersion="1" change="g.17416del">
            <Expression>NG_033943.1:g.17416del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282225.2" sequenceAccession="NM_001282225" sequenceVersion="2" change="c.239del" MANESelect="true">
            <Expression>NM_001282225.2:c.239del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001269154.1" sequenceAccession="NP_001269154" sequenceVersion="1" change="p.Phe80fs">
            <Expression>NP_001269154.1:p.Phe80fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282226.2" sequenceAccession="NM_001282226" sequenceVersion="2" change="c.239del">
            <Expression>NM_001282226.2:c.239del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001269155.1" sequenceAccession="NP_001269155" sequenceVersion="1" change="p.Phe80fs">
            <Expression>NP_001269155.1:p.Phe80fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282227.2" sequenceAccession="NM_001282227" sequenceVersion="2" change="c.113del">
            <Expression>NM_001282227.2:c.113del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001269156.1" sequenceAccession="NP_001269156" sequenceVersion="1" change="p.Phe38fs">
            <Expression>NP_001269156.1:p.Phe38fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282228.2" sequenceAccession="NM_001282228" sequenceVersion="2" change="c.113del">
            <Expression>NM_001282228.2:c.113del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001269157.1" sequenceAccession="NP_001269157" sequenceVersion="1" change="p.Phe38fs">
            <Expression>NP_001269157.1:p.Phe38fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001282229.2" sequenceAccession="NM_001282229" sequenceVersion="2" change="c.-38-2149del">
            <Expression>NM_001282229.2:c.-38-2149del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1217" sequenceAccession="LRG_1217">
            <Expression>LRG_1217:g.17416del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1217t1" sequenceAccession="LRG_1217t1">
            <Expression>LRG_1217t1:c.239del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1217p1" sequenceAccession="LRG_1217p1" change="p.Phe80fs">
            <Expression>LRG_1217p1:p.Phe80fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001282225.2(ADA2):c.239del (p.Phe80fs) AND Vasculitis due to ADA2 deficiency" Accession="RCV002837548" Version="2">
        <ClassifiedConditionList TraitSetID="13385">
          <ClassifiedCondition DB="MedGen" ID="C3887654">Vasculitis due to ADA2 deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-09-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-09-16" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-08" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">24552284</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24552285</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="13385" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6159" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Polyarteritis nodosa, childhoood-onset</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">VASCULITIS, AUTOINFLAMMATION, IMMUNODEFICIENCY, AND HEMATOLOGIC DEFECTS SYNDROME</ElementValue>
                <XRef Type="MIM" ID="615688" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607575.0009" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Vasculitis due to ADA2 deficiency</ElementValue>
                <XRef ID="MONDO:0014306" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">VAIHS</ElementValue>
                <XRef Type="MIM" ID="615688" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Adenosine deaminase 2 deficiency (DADA2) is a complex systemic autoinflammatory disorder in which vasculopathy/vasculitis, dysregulated immune function, and/or hematologic abnormalities may predominate. Inflammatory features include intermittent fevers, rash (often livedo racemosa/reticularis), and musculoskeletal involvement (myalgia/arthralgia, arthritis, myositis). Vasculitis, which usually begins before age ten years, may manifest as early-onset ischemic (lacunar) and/or hemorrhagic strokes, or as cutaneous or systemic polyarteritis nodosa. Hypertension and hepatosplenomegaly are often found. More severe involvement may lead to progressive central neurologic deficits (dysarthria, ataxia, cranial nerve palsies, cognitive impairment) or to ischemic injury to the kidney, intestine, and/or digits. Dysregulation of immune function can lead to immunodeficiency or autoimmunity of varying severity; lymphadenopathy may be present and some affected individuals have had lymphoproliferative disease. Hematologic disorders may begin early in life or in late adulthood, and can include lymphopenia, neutropenia, pure red cell aplasia, thrombocytopenia, or pancytopenia. Of note, both interfamilial and intrafamilial phenotypic variability (e.g., in age of onset, frequency and severity of manifestations) can be observed; also, individuals with biallelic ADA2 pathogenic variants may remain asymptomatic until adulthood or may never develop clinical manifestations of DADA2.</Attribute>
                <XRef ID="NBK544951" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12383" />
                <XRef ID="12383" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">31393689</ID>
                <ID Source="BookShelf">NBK544951</ID>
              </Citation>
              <XRef ID="404553" DB="Orphanet" />
              <XRef ID="C3887654" DB="MedGen" />
              <XRef ID="MONDO:0014306" DB="MONDO" />
              <XRef Type="MIM" ID="615688" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5893430" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="16871991|MedGen:C3887654" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003209313" DateUpdated="2024-02-20" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">24552284</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24552285</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with ADA2-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Phe80Serfs*23) in the ADA2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ADA2 are known to be pathogenic (PMID: 24552284, 24552285).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ADA2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000022.10:g.17690329del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3887654" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5893430" TraitType="Disease" MappingType="XRef" MappingValue="C3887654" MappingRef="MedGen">
        <MedGen CUI="C3887654" Name="Vasculitis due to ADA2 deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

